Abstract
In the last 15 years we have witnessed a remarkable improvement in the survival rates of children and adolescents with Hodgkin’s disease (HD) and non-Hodgkin’s lymphoma (NHL) — an improvement that continues today. Just 20 years ago, only some 30–40% of children with localized NHL could be expected to achieve longterm survival, and vanishingly few with extensive disease survived. Currently 80–90% of all lymphomas, HD and NHL, are curable. This progress has been the result of many factors, not the least of these being the conduct of controlled clinical trials. The well-organized and disciplined trials conducted during the last decade by the German group for pediatric HD (see Table 1) are a model in this regard [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schellong G, Brämswig H, Schwarze EW, Wannemacher M. An approach to reduce treatment and invasive staging in childhood Hodgkin’s disease: the sequence of the German DAL Multicenter Studies. Bull Cancer 1988; 75: 41–52.
Bowman WP, Shuster J, Cook B, Behm F, Berard C, Murphy SB. Results of treatment for advanced stage (IV) diffuse small non-cleaved cell non-Hodgkins (NHL) lymphomas and B(SIg+) cell acute lymphoblastic leukemia (ALL): The Pediatric Oncology Group (POG) Experience, 1986–89. Abstract -40. Fourth International Conference on Malignant Lymphoma, Lugano, June, 1990.
Patte C, Perel Y, Leverger G, Rubie H, Otten J, Plantaz D, Munzer M, Boutard P, Benz-Lemoine E, Pautard B, Kalifa C. High survival rate of B-cell non Hodgkin’s lymphomas (B-NHL) with CNS involvement (CNS+) and B-ALL. Results of the LBM 86 protocol of the French Pediatric Oncology Society (SFOP). Abstract -39. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Reiter A, Sauter S, Miiller-Weihrich S, Kühl J, Gadner H, Riehm H. BFM therapy strategy and results in advanced childhood B-cell neoplasias (stage-IV B-NHL; BALL). Abstract -38. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Schellong G, Hörnig-Franz I, Brämswig J, Wannenmacher M. Hodgkin’s disease in children: treatment reduction by elimination of procarbazine from OPPA/COPP chemotherapy. Results of the German Cooperative Study DAL-HD-85. Abstract -32. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Bessa E, Oberlin O, Hartman O, Michon J, Bordigoni J, Hervé P, Demeocq, Plantaz D, Philip T, Michel G, Baruchel A, Leverger G. High-dose combination chemotherapy for childhood Hodgkin’s disease: The French Pediatric Oncology Society Experience. Abstract -33. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Magrath IT, Adde M, Sandlund J, Jain V. Ifosfamide (IF) in the treatment of high-grade, recurrent B cell lymphomas: experience of the Pediatric Branch, National Cancer Institute. Abstract -37. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Gad-El-Mawla N, Hamza MR, Abdel-Hadi S, Hussein MH, El-Tannir O, Magrath I. Prolonged disease free survival in pediatric non-Hodgkin’s lymphoma using ifosfamide containing combination chemotherapy. Abstract -36. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Philip T, Pinkerton R, Hartmann O, Patte C, Philip I, Biron P, Favrot M. The role of massive therapy with autologous bone marrow transplantation in Burkitt’s lymphoma. Clinics in Haematology 1986; 15: (1) 205–17.
Agnarsson BA, Kadin ME. Ki-1 positive large cell lymphoma: a morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988; 12 (4): 264–74.
Bucsky P, Feller AC, Reiter A, Heitger A, Gadner H, Riehm H. Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in children and adolescents - preliminary experiences of the BFM Study Group. Abstract -34. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Vecchi V, Pileri S, Burnelli R, Rosito P, Pession A, Rondelli R, Borghetti A, Paolucci G. Anaplastic large-cell lymphoma (Ki1+/CD30+) in childhood. Abstract -35. Fourth International Conference on Malignant Lymphoma, Lugano, June 1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Murphy, S.B., Magrath, I.T. (1991). Workshop on pediatric lymphomas: Current results and prospects. In: Ultmann, J.E., Samuels, B.L. (eds) Annals of Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7305-4_35
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7305-4_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7294-1
Online ISBN: 978-1-4899-7305-4
eBook Packages: Springer Book Archive